Company Overview and News

3
California Dialysis Legislation Pummels DaVita Shares

2018-08-30 247wallst
The state of California has taken the first step to limit the price that dialysis centers will be allowed to charge patients. The state assembly late Wednesday passed the bill, which must now go the state senate for approval and then on to Governor Jerry Brown for signature. Senate passage is expected, but Brown has not indicated what he plans to do when the bill reaches his desk.
BRK.A FMS DVA ARA

 
American Renal Associates Holdings (ARA) CEO Joseph Carlucci on Q2 2018 Results - Earnings Call Transcript

2018-08-12 seekingalpha
American Renal Associates Holdings (NYSE:ARA) Q2 2018 Earnings Conference Call August 8, 2018 9:00 AM ET
ARA

 
American Renal Associates Holdings 2018 Q2 - Results - Earnings Call Slides

2018-08-09 seekingalpha
The following slide deck was published by American Renal Associates Holdings in conjunction with their 2018 Q2 earnings call.
ARA

 
ARA / American Renal Associates Holdings, Inc. 10-Q (Quarterly Report)

2018-08-08 sec.gov
Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION
ARA

20
Top Analyst Upgrades and Downgrades: Alcoa, Cisco, eBay, IBM, P&G, Square, Tesla, United Continental, Visa and More

2018-07-19 247wallst
Stocks were looking for direction on Wednesday with a fairly light day on economic data. Investors have had less faith and have seen lower rewards from buying the dips than in prior years. Many of those same investors also have been concerned about how they want their investments positioned ahead of the midterm elections, into international trade concerns and for into 2019 and beyond.
BMCH ABT AAI STCK CL CSCO AEP MS ARA AA EBAY ABT IBM V TRI CLX

4
ARA / American Renal Associates Holdings, Inc. null

2018-05-31 sec.gov
begin 644 filename1.pdf M)5!$1BTQ+C4-)>+CS],-"C
ARA

4
American Renal Associates Holdings' (ARA) CEO Joseph Carlucci on Q1 2018 Results - Earnings Call Transcript

2018-05-13 seekingalpha
American Renal Associates Holdings, Inc. (NYSE:ARA) Q1 2018 Earnings Conference Call May 9, 2018 9:00 AM ET
ARA

7
ARA / American Renal Associates Holdings, Inc. 10-Q (Quarterly Report)

2018-05-08 sec.gov - 3
Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION
ARA

4
ARA / American Renal Associates Holdings, Inc. null

2018-04-28 sec.gov
Document AMERICAN RENAL ASSOCIATES HOLDINGS, INC.
ARA

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...

Silicon Investor Message Boards

This table lists all message boards related to ARA / American Renal Associates Holdings, Inc. on message board site Silicon Investor.

Smartphones, Tablets, Wearables and Gadgets Smartphones, Tablets, Wearables and Gadgets Smartphones, Tablets, Wearables and Gadgets President Barack Obama President Barack Obama President Barack Obama
ARAY Accuray Cyberknife Robotic RadioSurgery ARAY Accuray Cyberknife Robotic RadioSurgery ARAY Accuray Cyberknife Robotic RadioSurgery ARADIGM CORP. ARDM ARADIGM CORP. ARDM ARADIGM CORP. ARDM
President Barack Obamau0027s Complete List of Historic Firsts President Barack Obamau0027s Complete List of Historic Firsts President Barack Obamau0027s Complete List of Historic Firsts Paramount Gold (PGDP) Paramount Gold (PGDP) Paramount Gold (PGDP)
Harvard Apparatus Regenerative Technology Harvard Apparatus Regenerative Technology Harvard Apparatus Regenerative Technology NIA.V - Niagara Ventures Corp (Blu-Dot Beverages) NIA.V - Niagara Ventures Corp (Blu-Dot Beverages) NIA.V - Niagara Ventures Corp (Blu-Dot Beverages)
Aradigm (ARDM) Aradigm (ARDM) Aradigm (ARDM) Oil prices boosted with Saudi Arabia-Iran tensions over Shiu0027 Oil prices boosted with Saudi Arabia-Iran tensions over Shiu0027 Oil prices boosted with Saudi Arabia-Iran tensions over Shiu0027
CUSIP: 029227105